News

29.05.2020 |

Profiting from health and ecological crisis in Africa: The Target Malaria project and new risky GE technologies

Second-generation GMOs produced from gene drive technologies, genome editing, paratransgenesis and cisgenesis are increasing the scope, scale, depth and flexibility of interventions that can be performed by the biotech industry, including genetically engineering of wild populations and ecosystems. Research and development (R&D) projects are largely financed by European and North American institutions; the Bill and Melinda Gates Foundation (BMGF); and the US military research arm – the US Defence Advanced Research Projects Agency (DARPA).

Zurück zu den Meldungen

EnglishFranceDeutsch